MiR-21 mediates the radiation resistance of glioblastoma cells by regulating PDCD4 and hMSH2

Abstract

The purpose of this study was to investigate the molecular mechanism by which miR-21 and its target genes mediate radiation resistance of glioblastoma cells. Real-time PCR was employed to detect miR-21 expression in normal brain tissues, glioblastoma tissues and glioblastoma cell lines (A172, T98G and U87MG). T98G cells were transfected with anti-miR-21 oligonucleotides, or plasmids containing PDCD4 or hMSH2 (PDCD4-pcDNA3 and hMSH2-pcDNA3). The survival curve was obtained to investigate the sensitivity of T98G cells to radiation. Cell apoptosis was measured by using the Caspase-3/7 kit and cell cycle by flow cytometry. Western blotting was performed to detect the expression of hMSH2 and PDCD4 in miR-21-inhibiting T98G cells. The results showed that miR-21 expression in glioblastoma cells and tissues was conversely associated with the radiation sensitivity. Over-expression of miR-21 resulted in radiation resistance, while knockdown of miR-21 led to higher sensitivity of glioblastma cells to radiation. After miR-21 knockdown, the apoptosis of T98G cells was significantly increased and the G2 phase arrest was more significant. In addition, miR-21 knockdown increased the expression of endogenous PDCD4 and hMSH2, which contributed to the apoptosis and G2 arrest of T98G cells. The findings suggested that miR-21 may mediate the resistance of glioblastoma cells against radiation via its target genes PDCD4 and hMSH2. MiR-21 and its target genes may be used as potential molecular targets for clinical radiotherapy sensitization in the future.

Keywords

microRNA / glioblastoma / radiation resistance / apoptosis / cell cycle

References

[1] TramacereF, GianicoloE, SerinelliM, et al.. Multivariate analysis of prognostic factors and survival in patients with “glioblastoma multiforme”. Clin Ter, 2008, 159(4): 233-238

[2] HorsmanMR, BohmL, MargisonGP, et al.. Tumor radiosensitizers-current status of development of various approaches: report of an International Atomic Energy Agency meeting. Int J Radiat Oncol Biol Phys, 2006, 64(2): 551-561

[3] LimLP, GlasnerME, YektaS, et al.. Vertebrate microRNA genes. Science, 2003, 299(5612): 1540

[4] ChanJA, KrichevskyAM, KosikKS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 2005, 65(14): 6029-6033

[5] MooreLM, ZhangW. Targeting miR-21 in glioma: a small RNA with big potential. Expert Opin Ther Targets, 2010, 14(11): 1247-1257

[6] PapagiannakopoulosT, ShapiroA, KosikKS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res, 2008, 68(19): 8164-8172

[7] ZhangY, ChaoT, LiR, et al.. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med(Berl), 2009, 87(1): 43-51

[8] ChenC, RidzonDA, BroomerAJ, et al.. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 2005, 33(20): e179

[9] ChenY, LiuW, ChaoT, et al.. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett, 2008, 272(2): 197-205

[10] Wada-HiraikeO, YanoT, NeiT, et al.. The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha. Br J Cancer, 2005, 92(12): 2286-2291

[11] PrevoR, DeutschE, SampsonO, et al.. Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. Cancer Res, 2008, 68(14): 5915-5923

[12] ZhangY, YuS, ZhuangL, et al.. Caveolin-1 is involved in radiation-induced ERBB2 nuclear transport in breast cancer cells. J Huazhong Univ Sci Technol [Med Sci], 2012, 32(6): 888-892

[13] OtomoT, HishiiM, AraiH, et al.. Microarray analysis of temporal gene responses to ionizing radiation in two glioblastoma cell lines: up-regulation of DNA repair genes. J Radiat Res, 2004, 45(1): 53-60

[14] KarimA, McCarthyK, JawaharA, et al.. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines. Anticancer Res, 2005, 25(1B): 675-679

[15] ValeriN, GaspariniP, BraconiC, et al.. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2(hMSH2). Proc Natl Acad Sci USA, 2010, 107(49): 21 098-21 103

[16] ZhongZ, DongZ, YangL, et al.. miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J Cancer Res Clin Oncol, 2012, 138(10): 1781-1788

[17] GabrielyG, WurdingerT, KesariS, et al.. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol, 2008, 28(17): 5369-5380

[18] ZhangS, WanY, PanT, et al.. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. J Mol Neurosci, 2012, 47(2): 346-356

[19] RenY, ZhouX, MeiM, et al.. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251(PTEN-mutant) and LN229(PTEN-wild type) to taxol. BMC Cancer, 2010, 10: 27

[20] AnastasovNA, HofigI, VasconcellosIG, et al.. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiat Oncol, 2012, 7(1): 206

[21] LiX, ChenX, HuangS, et al.. Down-regulation of miR-21 expression enhances the radiosensitivity of TE-1 cells in vitro. Nanfang Yike Daxue Xuebao(Chinese), 2012, 32(11): 1559-1563

[22] BuscagliaLE, LiY. Apoptosis and the target genes of microRNA-21. Chin J Cancer, 2011, 30(6): 371-380